We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.67B
AUM Growth
-$255M
Cap. Flow
-$501M
Cap. Flow %
-18.76%
Top 10 Hldgs %
64.43%
Holding
673
New
208
Increased
118
Reduced
162
Closed
161

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$268M
2
AMZN icon
Amazon
AMZN
+$226M
3
BSX icon
Boston Scientific
BSX
+$55.2M
4
PYPL icon
PayPal
PYPL
+$42.9M
5
ADBE icon
Adobe
ADBE
+$33.3M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$241M
2
MU icon
Micron Technology
MU
+$171M
3
INTC icon
Intel
INTC
+$163M
4
MSFT icon
Microsoft
MSFT
+$121M
5
AAPL icon
Apple
AAPL
+$112M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.16%
2 Technology 19.26%
3 Healthcare 6%
4 Financials 5.81%
5 Energy 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSLR icon
326
First Solar
FSLR
$25.7B
$624K 0.02%
2,500
-8,205
-77% -$1.85M
ALKT icon
327
Alkami Technology
ALKT
$2.1B
$622K 0.02%
19,727
+3,994
+25% +$126K
ATAT icon
328
Atour Lifestyle Holdings
ATAT
$4.85B
$618K 0.02%
+23,832
New +$443K
REGN icon
329
Regeneron Pharmaceuticals
REGN
$83.2B
$618K 0.02%
588
-562
-49% -$625K
CVS icon
330
CVS Health
CVS
$122B
$617K 0.02%
+9,811
New +$572K
NTCT icon
331
NETSCOUT
NTCT
$2.81B
$615K 0.02%
28,266
-5,565
-16% -$110K
SWBI icon
332
Smith & Wesson
SWBI
$636M
$613K 0.02%
47,256
+28,289
+149% +$409K
MHK icon
333
Mohawk Industries
MHK
$9.19B
$608K 0.02%
+3,783
New +$544K
EXPE icon
334
Expedia Group
EXPE
$37.7B
$605K 0.02%
+4,088
New +$542K
FFIV icon
335
F5
FFIV
$23.2B
$604K 0.02%
+2,745
New +$532K
OKTA icon
336
Okta
OKTA
$26.2B
$604K 0.02%
+8,125
New +$710K
INSM icon
337
Insmed
INSM
$29.4B
$604K 0.02%
+8,269
New +$610K
RYTM icon
338
Rhythm Pharmaceuticals
RYTM
$7.95B
$602K 0.02%
+11,491
New +$551K
MTTR
339
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$599K 0.02%
+133,189
New +$581K
CRAI icon
340
CRA International
CRAI
$1.06B
$597K 0.02%
+3,405
New +$568K
FATE icon
341
Fate Therapeutics
FATE
$322M
$588K 0.02%
167,957
-4,906
-3% -$19.1K
NUS icon
342
Nu Skin
NUS
$250M
$580K 0.02%
78,736
+29,894
+61% +$279K
EGBN icon
343
Eagle Bancorp
EGBN
$843M
$579K 0.02%
25,622
-48,369
-65% -$1.01M
ZYME icon
344
Zymeworks
ZYME
$1.71B
$575K 0.02%
+45,810
New +$499K
CFFN icon
345
Capitol Federal Financial
CFFN
$1.08B
$565K 0.02%
96,693
-47,042
-33% -$277K
SAH icon
346
Sonic Automotive
SAH
$2.53B
$554K 0.02%
+9,473
New +$546K
AXON
347
Axon Enterprise
AXON
$48.4B
$548K 0.02%
+1,371
New +$473K
CARG icon
348
CarGurus
CARG
$3.35B
$547K 0.02%
18,228
-789
-4% -$21.3K
BV icon
349
BrightView Holdings
BV
$1.05B
$547K 0.02%
34,776
-17,670
-34% -$256K
POWL icon
350
Powell Industries
POWL
$7.55B
$538K 0.02%
7,272
-15,183
-68% -$826K
12 13
14
15 16

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q3 2024 Portfolio in Review

As of Q3 2024, Caxton Associates (New York) held 673 positions worth $2.67B, down 8.7% from $2.93B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Caxton Associates (New York) withdrew a net $501M in Q3 2024, closing 161 positions and reducing 162 holdings. Its most notable exit was Micron Technology, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Caxton Associates (New York) opened a new position in Boston Scientific worth $58.7M.

  • Caxton Associates (New York)'s largest Q3 2024 buy was Boston Scientific: 700,000 shares worth $58.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2024, an estimated $268M increase.
  • Caxton Associates (New York)'s biggest Q3 2024 reduction was Citigroup, cutting an estimated $241M.
  • Caxton Associates (New York) fully exited Micron Technology in Q3 2024, selling an estimated $171M.
  • Caxton Associates (New York)'s ten largest holdings make up 64% of its $2.67B portfolio in Q3 2024.
  • Caxton Associates (New York) opened 208 new positions and closed 161 in Q3 2024.
  • Caxton Associates (New York)'s portfolio value fell 8.7% quarter-over-quarter to $2.67B.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.